Table 3.
Preop baseline | Day 1 | Day 2 | Day 3 | Day 4 | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
N | V | R | N | V | R | N | V | R | N | V | R | N | V | R | |
None of the time (%) | 207 (90%) | 220 (95%) | 217 (94%) | 174 (78%) | 222 (99%) | 215 (97%) | 160 (71%) | 219 (97%) | 215 (96%) | 173 (77%) | 220 (98%) | 214 (96%) | 166 (77%) | 210 (98%) | 205 (98%) |
Some of the time | 21 | 10 | 12 | 44 | 2 | 6 | 51 | 4 | 9 | 36 | 5 | 8 | 40 | 3 | 5 |
Usually | 2 | 0 | 0 | 4 | 0 | 1 | 3 | 1 | 0 | 3 | 0 | 1 | 3 | 1 | 2 |
Most of the time | 1 | 1 | 1 | 1 | 0 | 0 | 10 | 0 | 0 | 7 | 0 | 0 | 4 | 1 | 1 |
All of the time | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 3 | 0 | 0 | 2 | 0 | 0 |
Respondents | 231 | 223 | 225 | 224 | 215 | ||||||||||
Patients with Any Positive Responses (%) | 28 (12%) | 53 (24%) | 67 (30%) | 57 (26%) | 52 (24%) |
Preop: preoperative; N: nausea; V: vomiting; R: retching (dry)
There were no significant demographic differences between respondents and non-respondents
There were no significant differences among nerve block treatment groups